search
Back to results

Vanguard Knee Anterior Stabilized Versus Posterior Stabilized Bearing Study (VGASPS)

Primary Purpose

Osteoarthritis, Degenerative Arthritis

Status
Withdrawn
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Vanguard Knee System with AS Bearing
Vanguard Knee System with PS Bearing
Sponsored by
Zimmer Biomet
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Osteoarthritis focused on measuring knee, osteoarthritis, joint, replacement, knee surgery

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria are identical to the indications stated in the FDA approved labeling for the device 510(k) K023546, K033489, and K050222. These indications are stated below:

  • Painful and disabled knee joint resulting from osteoarthritis, rheumatoid arthritis, traumatic arthritis where one or more compartments are involved.
  • Correction of varus, valgus, or posttraumatic deformity.
  • Correction or revision of unsuccessful osteotomy, or arthrodesis.

Patient selection factors to be considered include:

  • Need to obtain pain relief and improve function
  • Ability and willingness of the patient to follow instructions, including control of weight and activity level
  • A good nutritional state of the patient
  • The patient must have reached full skeletal maturity

Exclusion criteria will be identical to the contraindications stated in the FDA approved labeling for the device 510(k) K023546, K033489, and K050222.

These contraindications are stated below:

-Absolute contraindications include: infection, sepsis, osteomyelitis, and failure of a previous joint replacement.

Relative contraindications include:

  • Uncooperative patient or patient with neurologic disorders who are incapable of following directions
  • Osteoporosis,
  • Metabolic disorders which may impair bone formation
  • Osteomalacia
  • Distant foci of infections which may spread to the implant site,
  • Rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram,
  • Vascular insufficiency, muscular atrophy, neuromuscular disease,
  • Incomplete or deficient soft tissue surrounding the knee

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Other

    Other

    Arm Label

    Posterior Stabilized

    Anterior Stablized

    Arm Description

    Patients who received a PS (Posterior Stabilized) Tibial Bearing.

    Patients who received an AS (Anterior Stabilized) Tibial Bearing

    Outcomes

    Primary Outcome Measures

    Objective Knee Score
    Average objective knee score; includes a combination of range of motion and pain scores.

    Secondary Outcome Measures

    Knee Society Score
    Average total knee score. Includes the objective and functional aspects of the knee score.
    Dislocation
    Rate of Dislocation as reported by patients in a complication.
    Survivorship
    Reports surivival of implant.
    Reports of Radiographic Loosening via Complication Form
    A more specific survivorship element; will indicate rate of loosening if it occurs.

    Full Information

    First Posted
    June 2, 2010
    Last Updated
    June 19, 2017
    Sponsor
    Zimmer Biomet
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT01308515
    Brief Title
    Vanguard Knee Anterior Stabilized Versus Posterior Stabilized Bearing Study
    Acronym
    VGASPS
    Official Title
    A Comparative Clinical Evaluation of the Vanguard Knee System's Anterior Stabilized & Posterior Stabilized Tibial Bearings
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    June 2017
    Overall Recruitment Status
    Withdrawn
    Why Stopped
    Could not find interested researchers/clinicians to complete study protocol.
    Study Start Date
    September 2010 (undefined)
    Primary Completion Date
    September 2010 (Anticipated)
    Study Completion Date
    September 2010 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Zimmer Biomet

    4. Oversight

    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The purpose of this study is to compare the performance of two FDA-cleared tibial bearings (replacement for cartilage in the knee) by collecting data on patients through 3 years of follow-up.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Osteoarthritis, Degenerative Arthritis
    Keywords
    knee, osteoarthritis, joint, replacement, knee surgery

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    0 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Posterior Stabilized
    Arm Type
    Other
    Arm Description
    Patients who received a PS (Posterior Stabilized) Tibial Bearing.
    Arm Title
    Anterior Stablized
    Arm Type
    Other
    Arm Description
    Patients who received an AS (Anterior Stabilized) Tibial Bearing
    Intervention Type
    Device
    Intervention Name(s)
    Vanguard Knee System with AS Bearing
    Intervention Description
    FDA cleared Tibial bearing that stabilizes the knee with an anterior lip, and is used with FDA cleared Vanguard CR (Cruciate Retaining) Femoral Component.
    Intervention Type
    Device
    Intervention Name(s)
    Vanguard Knee System with PS Bearing
    Intervention Description
    FDA cleared Tibial bearing that stabilizes the knee with a post that articulates with the FDA cleared Vanguard PS(Posterior Stabilizing) Femoral Component.
    Primary Outcome Measure Information:
    Title
    Objective Knee Score
    Description
    Average objective knee score; includes a combination of range of motion and pain scores.
    Time Frame
    1 Year Post-op
    Secondary Outcome Measure Information:
    Title
    Knee Society Score
    Description
    Average total knee score. Includes the objective and functional aspects of the knee score.
    Time Frame
    3 Years
    Title
    Dislocation
    Description
    Rate of Dislocation as reported by patients in a complication.
    Time Frame
    3 Years
    Title
    Survivorship
    Description
    Reports surivival of implant.
    Time Frame
    3 Years
    Title
    Reports of Radiographic Loosening via Complication Form
    Description
    A more specific survivorship element; will indicate rate of loosening if it occurs.
    Time Frame
    3 Years

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria are identical to the indications stated in the FDA approved labeling for the device 510(k) K023546, K033489, and K050222. These indications are stated below: Painful and disabled knee joint resulting from osteoarthritis, rheumatoid arthritis, traumatic arthritis where one or more compartments are involved. Correction of varus, valgus, or posttraumatic deformity. Correction or revision of unsuccessful osteotomy, or arthrodesis. Patient selection factors to be considered include: Need to obtain pain relief and improve function Ability and willingness of the patient to follow instructions, including control of weight and activity level A good nutritional state of the patient The patient must have reached full skeletal maturity Exclusion criteria will be identical to the contraindications stated in the FDA approved labeling for the device 510(k) K023546, K033489, and K050222. These contraindications are stated below: -Absolute contraindications include: infection, sepsis, osteomyelitis, and failure of a previous joint replacement. Relative contraindications include: Uncooperative patient or patient with neurologic disorders who are incapable of following directions Osteoporosis, Metabolic disorders which may impair bone formation Osteomalacia Distant foci of infections which may spread to the implant site, Rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram, Vascular insufficiency, muscular atrophy, neuromuscular disease, Incomplete or deficient soft tissue surrounding the knee
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Ken Beres, MD
    Organizational Affiliation
    Biomet (no investigators were selected for this study)
    Official's Role
    Study Director

    12. IPD Sharing Statement

    Learn more about this trial

    Vanguard Knee Anterior Stabilized Versus Posterior Stabilized Bearing Study

    We'll reach out to this number within 24 hrs